This Article Full Text Full Text (PDF) All Versions of this Article: j.jacc.2007.05.015v1 50/8/727    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (2) Citing Articles via Google Scholar Google Scholar Articles by Robin, N. H. Articles by Korf, B. R. Search for Related Content PubMed Articles by Robin, N. H. Articles by Korf, B. R.

CARDIOVASCULAR GENOMIC MEDICINE

Genetic Testing in Cardiovascular Disease

Nathaniel H. Robin, MD^_*, Paul B. Tabereaux, MD, MPH, Raymond Benza, MD and Bruce R. Korf, MD, PhD^_*,_*

^_* Department of Genetics, University of Alabama at Birmingham, Birmingham, Alabama
Division of Cardiology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.

Manuscript received May 19, 2006; revised manuscript received April 16, 2007, accepted May 1, 2007.

^_* Reprint requests and correspondence: Dr. Bruce R. Korf, Department of Genetics, University of Alabama at Birmingham, 1530 3rd Avenue South, Kaul 230, Birmingham, Alabama 35294. (Email: bkorf{at}uab.edu).

Genetic testing is increasingly becoming possible for diagnosis, susceptibility testing, and prognostication in cardiovascular medicine. The practicing cardiologist, therefore, needs to be familiar with the clinical utilities and limitations of genetic testing. This review explores the major approaches to genetic testing and issues in test interpretation. Specific applications to cardiovascular diseases, including coronary artery disease, cardiomyopathies, cardiac arrhythmias, and pulmonary arterial hypertension are discussed.

Abbreviations and Acronyms   ARVC = arrythmogenic right ventricular dysplasia/cardiomyopathy   CAD = coronary artery disease   CM = cardiomyopathy   CPVT = catecholaminergic polymorphic ventricular tachycardia   DCM = dilated cardiomyopathy   DCM-CCD = dilated cardiomyopathy associated with cardiac conduction defects   FDCM = familial dilated cardiomyopathy   FH = familial hypercholesterolemia   HCM = hypertrophic cardiomyopathy   INVM = isolated noncompaction of the ventricular myocardium   LDL = low-density lipoprotein   LDLR = low-density lipoprotein receptor   LQTS = long QT syndrome   MI = myocardial infarction   PAH = pulmonary arterial hypertension   PCCD = progressive cardiac conduction defect   PPH = primary pulmonary hypertension   RCM = restrictive cardiomyopathy   SNP = single nucleotide polymorphism

This article has been cited by other articles:

				K. M. Brauch, M. L. Karst, K. J. Herron, M. de Andrade, P. A. Pellikka, R. J. Rodeheffer, V. V. Michels, and T. M. Olson Mutations in ribonucleic Acid binding protein gene cause familial dilated cardiomyopathy. J. Am. Coll. Cardiol., September 1, 2009; 54(10): 930 - 941. [Abstract] [Full Text] [PDF]

				R. E. Hershberger, J. Cowan, A. Morales, and J. D. Siegfried Progress With Genetic Cardiomyopathies: Screening, Counseling, and Testing in Dilated, Hypertrophic, and Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Circ Heart Fail, May 1, 2009; 2(3): 253 - 261. [Abstract] [Full Text] [PDF]

				W.H. W. Tang and G. S. Francis The Year in Heart Failure J. Am. Coll. Cardiol., December 11, 2007; 50(24): 2344 - 2351. [Full Text] [PDF]